June 2011 FDA Recall Albuterol Sulfate by Nephron Pharmaceuticals Corp.
D-1446-2012 - Lack of Assurance of Sterility

This Class II drug recall was voluntarily initiated by Nephron Pharmaceuticals Corp. on June 22, 2011 for the product Albuterol Sulfate. The FDA reported the reason for recall as lack of assurance of sterility. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1446-2012

Reason for Recall
Lack of Assurance of Sterility
Initiated
06-22-2011
Reported
08-15-2012
Quantity
56,028 cartons

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Nephron Pharmaceuticals Corp.
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Nationwide and Puerto Rico
Albuterol Sulfate Inhalation Solution, 0.083%, 2.5 mg/3 mL Sterile Unit-Dose Vials, 60-count (60 x 3 mL Sterile Unit-Dose Vials) per carton, Rx only, Manufactured by: nephron pharmaceuticals corporation, Orlando, FL 32811, NDC 0487-9501-60.

Batch or Lot Expiration Information

Lot# : A0654A, Exp 07/12; A0A62A, Exp 10/12